Robert B. Cameron

Chief, Thoracic Surgery

VA Greater Los Angeles Healthcare System

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Robert B. Cameron is the Chief of Thoracic Surgery at the VA Greater Los Angeles Healthcare System in the United States. His research focuses on various aspects of thoracic surgery, including management of chest wall pain, innovations in surgical techniques, and immunotherapy in lung cancer. He has contributed significantly to the understanding of postoperative esophageal function and tumor-treating fields in malignant pleural mesothelioma through his recent publications.

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Jie Deng

University of California, Los Angeles

UNITED STATES

View details

mahsa ghovvati

University of California, Los Angeles

UNITED STATES

View details

Saumya Jain

University of California, Los Angeles

UNITED STATES

View details

Jun Zhang

Associate Professor

University of Kansas Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert B. Cameron

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Rapid closure and hemostasis of ruptured soft tissues using a modified human tropoelastin-based sealant in preclinical models

Double lumen endobronchial tube intubation: lessons learned from anatomy

Pathophysiology and Management of Chest Wall Pain after Surgical and Non-Surgical Local Therapies for Lung Cancer

Multi-Institutional Patterns of Use of Tumor-Treating Fields for Patients with Malignant Pleural Mesothelioma.

Commentary: Postoperative esophageal function: Important lessons for cardiac surgeons to swallow

What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?

Adjuvant nivolumab after preoperative chemoradiotherapy and surgery in esophageal cancer: A shifting paradigm

Commentary: Bronchopleural Fistulae: Are Fibroblasts Necessarily the Real Answer?

Commentary: Great toenail grafts for tracheal reconstruction: Adopt it or kick it to the curb—your choice

Commentary: Thoracic intensive care unit readmissions—glass half full or half empty?

EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study

Collaborators (4)

Jie Deng

mahsa ghovvati

Saumya Jain

Jun Zhang

Make your next move.